Cargando…
Response to Morita et al., Re: Continuous Deep Sedation (DOI: 10.1089/pmr.2021.0058)
Autor principal: | Broeckaert, Bert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279116/ https://www.ncbi.nlm.nih.gov/pubmed/35919383 http://dx.doi.org/10.1089/pmr.2022.0018 |
Ejemplares similares
-
Response to Morita et al., Re: Defining “Continuous Deep Sedation” Using Treatment Protocol (DOI: 10.1089/pmr.2021.0058)
por: Twycross, Robert G.
Publicado: (2022) -
Response to Pairojkul et al. Integration of Specialist Palliative Care into Tertiary Hospitals: A Multicenter Point Prevalence Survey from Thailand (DOI: 10.1089/pmr.2021.0003)
por: Mungmunpuntipatip, Rujittika, et al.
Publicado: (2022) -
Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036
por: Bonn-Miller, Marcel O., et al.
Publicado: (2017) -
Response to Tark et al. (doi: 10.1089/jpm.2018.0626): Variations in Physician Orders for Life-Sustaining Treatment Program across the Nation: Environmental Scan
por: Jimenez, Valerie M., et al.
Publicado: (2019) -
Even High Doses of Oral Cannabidiol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102–112; DOI: 10.1089/can.2015.0004
por: Grotenhermen, Franjo, et al.
Publicado: (2017)